Statement regarding Spire Healthcare Group

Summary by AI ^BETAClose X

Bridgepoint Advisers Limited has announced that it does not intend to make an offer for Spire Healthcare Group plc, following its participation in the Formal Sale Process. Bridgepoint stated it was unable to achieve sufficient confidence in a transaction structure that would be suitable for all stakeholders at this time. As a result of this announcement, Bridgepoint is now bound by Rule 2.8 of the UK City Code on Takeovers and Mergers, which restricts it from making or participating in an offer for Spire Healthcare for a period of six months, except under specific circumstances outlined in the Code.

Disclaimer*

Bridgepoint Advisers Limited

20 March 2026

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE UK CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

20 March 2026

Statement regarding Spire Healthcare Group plc ("Spire Healthcare", the "Company")

Further to the announcement by Spire Healthcare on 18 February, Bridgepoint Advisers Limited ("Bridgepoint") confirms that it does not intend to make an offer for Spire Healthcare.

Bridgepoint is grateful for the efforts of the Spire Healthcare Board over the course of its participation in the Formal Sale Process, but Bridgepoint has been unable to get sufficient confidence as to a transaction structure that would work for all stakeholders at this time.

As a result of this announcement, Bridgepoint will, except with the consent of the UK Panel on Takeovers and Mergers (the "Panel"), be bound by the restrictions contained in Rule 2.8 of the Code.

For the purposes of Rule 2.8 of the Code, Bridgepoint reserve the right, either together or individually, to announce or participate in an offer or possible offer for Spire Healthcare and/or to take any other action which would otherwise be restricted under Rule 2.8 of the Code within 6 months after the date of this announcement in the following circumstances described in note 2 to Rule 2.8 of the Code: (i) with the consent of the Board of Spire Healthcare; (ii) if a third party announces a firm intention to make an offer for Spire Healthcare; (iii) if Spire Healthcare announces a Rule 9 waiver proposal (see Note 1 of the Notes on Dispensations from Rule 9) or a reverse takeover (as defined in the Code); or (iv) if the Panel determines there has been a material change of circumstances.

Enquiries:

Bridgepoint

Christian Jones +44 (0) 20 7034 3500

Nicole Gregory

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END